+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Barrett's esophagus: update on screening, surveillance, and treatment

Barrett's esophagus: update on screening, surveillance, and treatment

Archives of Internal Medicine 159(13): 1411-1416

The last 2 decades have seen dramatic advances in Barrett's esophagus. The definition has evolved; the rising incidence of adenocarcinoma has been recognized; and effective therapy to control gastroesophageal reflux disease has been developed. Both proton pump inhibitor therapy and laparoscopic fundoplication represent major developments. Studies of patients with dysplasia have helped to clarify appropriate surveillance intervals and treatment strategies for these patients, although controversy still exists. The possibility of reversing Barrett's esophagus in selected high-risk patients offers major hope for the future prevention of adenocarcinoma of the esophagus.

(PDF emailed within 1 workday: $29.90)

Accession: 010228797

Download citation: RISBibTeXText

PMID: 10399892

Related references

Not all of Barrett's esophagus surveillance protocols are created equal: the dangers of retrospective outcome research in the treatment of Barrett's esophagus. Gastrointestinal Endoscopy 80(6): 1203, 2015

Screening and surveillance for Barrett esophagus. JAMA Internal Medicine 175(2): 159-160, 2015

Screening and surveillance of Barrett's esophagus. Current Gastroenterology Reports 11(3): 195-201, 2009

Screening And Surveillance In Barrett'S Esophagus: Much To Be Known. Evidence-Based Gastroenterology 3(3): 76-77, 2002

How far to go? Screening and surveillance in Barrett's esophagus. American Journal of Managed Care 7(1 Suppl): S19-S26, 2001

Surveillance and screening for Barrett esophagus and adenocarcinoma. Journal of Clinical Gastroenterology 39(4 Suppl 2): S33-S41, 2005

Screening for and surveillance of Barrett's esophagus is clinically indicated. Digestive Diseases 25(3): 197-202, 2007

Barrett's esophagus: novel strategies for screening and surveillance. Therapeutic Advances in Chronic Disease 10: 2040622319837851, 2019

Sa1135 Genomic Biomarkers for Cancer Risk in Barrett's Esophagus: An Update on the Longitudinal Dutch Barrett's Esophagus Cohort. Gastroenterology 156(6): S-279-S-280, 2019

Evolving screening and surveillance techniques for Barrett's esophagus. World Journal of Gastroenterology 25(17): 2045-2057, 2019

Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?. Digestive Diseases and Sciences 63(8): 2094-2104, 2018

The field effect in Barrett's esophagus: can we use it for screening and surveillance?. Endoscopy 45(12): 989-991, 2014

Barrett's Esophagus: Diagnosis, Screening, Surveillance, and Controversies. Gut and Liver 1(2): 93-100, 2007

Screening and surveillance in Barrett's esophagus: a call to action. Clinical Gastroenterology and Hepatology 2(10): 861-864, 2004

Critical appraisal of guidelines for screening and surveillance of Barrett's esophagus. Annals of Translational Medicine 6(13): 259, 2018